PubRank

Terri Warren

Author PubWeight™ 34.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004 5.04
2 Genital herpes. Lancet 2007 3.83
3 Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis 2004 3.23
4 Helicase-primase inhibitor pritelivir for HSV-2 infection. N Engl J Med 2014 2.36
5 A phase I study of weekly R1507, a human monoclonal antibody insulin-like growth factor-I receptor antagonist, in patients with advanced solid tumors. Clin Cancer Res 2010 1.96
6 Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 2011 1.85
7 From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis 2008 1.58
8 Genital shedding of herpes simplex virus among men. J Infect Dis 2002 1.42
9 Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial. J Infect Dis 2007 1.37
10 A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects. Vaccine 2005 1.09
11 Persistent genital herpes simplex virus-2 shedding years following the first clinical episode. J Infect Dis 2010 1.03
12 One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection. Sex Transm Dis 2008 0.98
13 Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons. Vaccine 2011 0.94
14 Phase I dose-escalation study of a monovalent heat shock protein 70-herpes simplex virus type 2 (HSV-2) peptide-based vaccine designed to prime or boost CD8 T-cell responses in HSV-naïve and HSV-2-infected subjects. Clin Vaccine Immunol 2008 0.93
15 Phase I clinical trial of MPC-6827 (Azixa), a microtubule destabilizing agent, in patients with advanced cancer. Mol Cancer Ther 2010 0.93
16 Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects. J Infect Dis 2003 0.89
17 Famciclovir reduces viral mucosal shedding in HSV-seropositive persons. Sex Transm Dis 2007 0.85
18 Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding. Sex Transm Dis 2006 0.84
19 APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding. Sex Transm Infect 2010 0.82
20 Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test. J Clin Microbiol 2012 0.80
21 Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life. Sex Transm Dis 2007 0.78
22 Polymorphisms in the genes for herpesvirus entry. J Infect Dis 2002 0.75
23 Getting tested for herpes. FDA Consum 2002 0.75
24 Performance of Commercial Enzyme-Linked Immunoassays for Diagnosis of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 Infection in a Clinical Setting. Sex Transm Dis 2017 0.75